Trial Profile
An observational, single centre study comparing the efficacy and safety of dabigatran versus acenocumarol in patients with non-valvular atrial fibrillation in a 24 months follow up: a real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Acenocoumarol (Primary) ; Dabigatran etexilate (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 02 Sep 2016 New trial record